{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:05:33Z","timestamp":1790024733177,"version":"4.0.1"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"abstract":"Abstract<\/jats:title>\n \n Purpose<\/jats:title>\n To provide a comprehensive overview of the existing understanding regarding the clinical characteristics, diagnostic investigation, and treatment strategies for autoimmune retinopathy (AIR). To emphasize the lack of consensus in the field and the ongoing controversies regarding best practices.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Narrative review of the literature on PubMed and Google Scholar databases.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n AIR comprises a group of rare autoimmune disorders causing retinal degeneration, characterized by rapid vision deterioration linked to circulating anti-retinal autoantibodies (ARAs). The spectrum includes primary autoimmune diseases and associations with retinitis pigmentosa or various malignancies, raising questions about the causative role of antibodies. Non-paraneoplastic AIR patients may be younger on average than paraneoplastic AIR patients and may have a higher likelihood of being female and having a history of autoimmune disease. Diagnosing AIR is challenging due to its complex pathophysiology, overlapping phenotypes, the absence of standardized diagnostic criteria, and the limited availability of specialized serological testing for ARAs. Despite decades of research progress, the exact mechanisms underlying ocular immune privilege breakdown and the autoimmune attack on retinal cells in AIR remain unknown.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The diagnosis and management of AIR present ongoing challenges, with no international consensus on diagnostic criteria or treatment protocols. While several authors consider the identification of circulating ARAs crucial for diagnosis, there is disagreement on the pathogenicity of specific antibodies, including anti-recoverin. The lack of randomized controlled trials and a universally accepted treatment protocol for AIR further contribute to uncertainties in its management. Despite recent advances, AIR remains an enigmatic condition, necessitating further research to establish standardized diagnostic and therapeutic guidelines.<\/jats:p>\n <\/jats:sec>","DOI":"10.1007\/s10792-025-03696-y","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T10:51:52Z","timestamp":1755514312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Diagnosis and treatment of autoimmune retinopathy: review of current approaches"],"prefix":"10.1007","volume":"45","author":[{"given":"Dimitrios","family":"Kalogeropoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew John","family":"Lotery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Pavesio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Kalogeropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Kanavaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Shawkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"De Salvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"4\u20135","key":"3696_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.autrev.2014.01.039","volume":"13","author":"T Braithwaite","year":"2014","unstructured":"Braithwaite T, Holder GE, Lee RW et al (2014) Diagnostic features of the autoimmune retinopathies. Autoimmun Rev 13(4\u20135):534\u2013538. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.039","journal-title":"Autoimmun Rev"},{"issue":"3","key":"3696_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000338240","volume":"228","author":"T Braithwaite","year":"2012","unstructured":"Braithwaite T, Vugler A, Tufail A (2012) Autoimmune retinopathy. Ophthalmologica 228(3):131\u2013142. https:\/\/doi.org\/10.1159\/000338240","journal-title":"Ophthalmologica"},{"issue":"3","key":"3696_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1159\/000338240","volume":"105","author":"CE Thirkill","year":"1987","unstructured":"Thirkill CE, Roth AM, Keltner JL (1987) Cancer-associated retinopathy. Arch Ophthalmol 105(3):372\u2013375. https:\/\/doi.org\/10.1159\/000338240","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"3696_CR4","first-page":"2768","volume":"33","author":"CE Thirkill","year":"1992","unstructured":"Thirkill CE, Tait RC, Tyler NK et al (1992) The cancer-associated retinopathy antigen is a recoverin-like protein. Investig Ophthalmol Vis Sci 33(10):2768\u20132772","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"9","key":"3696_CR5","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.4103\/ijo.IJO_786_20","volume":"68","author":"P Dutta Majumder","year":"2020","unstructured":"Dutta Majumder P, Marchese A, Pichi F et al (2020) An update on autoimmune retinopathy. Indian J Ophthalmol 68(9):1829\u20131837. https:\/\/doi.org\/10.4103\/ijo.IJO_786_20","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"3696_CR6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/0002-9394(76)90125-2","volume":"81","author":"RA Sawyer","year":"1976","unstructured":"Sawyer RA, Selhorst JB, Zimmerman LE et al (1976) Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 81(5):606\u2013613. https:\/\/doi.org\/10.1016\/0002-9394(76)90125-2","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"3696_CR7","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/1097-0142(19821001)50:7<1289::aid-cncr2820500711>3.0.co;2-9","volume":"50","author":"SE Kornguth","year":"1982","unstructured":"Kornguth SE, Klein R, Appen R, Choate J (1982) Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer 50(7):1289\u20131293. https:\/\/doi.org\/10.1002\/1097-0142(19821001)50:7%3c1289::aid-cncr2820500711%3e3.0.co;2-9","journal-title":"Cancer"},{"issue":"4","key":"3696_CR8","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/archopht.1983.01040010564006","volume":"101","author":"JL Keltner","year":"1983","unstructured":"Keltner JL, Roth AM, Chang RS (1983) Photoreceptor degeneration. Possible autoimmune disorder. Arch Ophthalmol 101(4):564\u2013569. https:\/\/doi.org\/10.1001\/archopht.1983.01040010564006","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"3696_CR9","first-page":"239","volume":"4","author":"TG Klingele","year":"1984","unstructured":"Klingele TG, Burde RM, Rappazzo JA et al (1984) Paraneoplastic retinopathy. J Clin Neuroophthalmol 4(4):239\u2013245","journal-title":"J Clin Neuroophthalmol"},{"key":"3696_CR10","unstructured":"Gass JD (1984) Acute Vogt-Koyonagi-Harada-like syndrome occurring in a patient with metastatic cutaneous melanoma. Paper presented at: uveitis update: proceedings of the first international symposium on uveitis. Amsterdam, The Netherlands"},{"issue":"3","key":"3696_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0002-9394(88)90366-2","volume":"106","author":"EL Berson","year":"1988","unstructured":"Berson EL, Lessell S (1988) Paraneoplastic night blindness with malignant melanoma. Am J Ophthalmol 106(3):307\u2013311. https:\/\/doi.org\/10.1016\/0002-9394(88)90366-2","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"3696_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/s0002-9394(14)71073-6","volume":"123","author":"JB Mizener","year":"1997","unstructured":"Mizener JB, Kimura AE, Adamus G et al (1997) Autoimmune retinopathy in the absence of cancer. Am J Ophthalmol 123(5):607\u2013618. https:\/\/doi.org\/10.1016\/s0002-9394(14)71073-6","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"3696_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ajo.2013.09.019","volume":"157","author":"L Grange","year":"2014","unstructured":"Grange L, Dalal M, Nussenblatt RB et al (2014) Autoimmune retinopathy. Am J Ophthalmol 157(2):266-272.e1. https:\/\/doi.org\/10.1016\/j.ajo.2013.09.019","journal-title":"Am J Ophthalmol"},{"key":"3696_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ajo.2016.05.013","volume":"168","author":"AR Fox","year":"2016","unstructured":"Fox AR, Gordon LK, Heckenlively JR et al (2016) Consensus on the diagnosis and management of nonparaneoplastic autoimmune retinopathy using a modified delphi approach. Am J Ophthalmol 168:183\u2013190. https:\/\/doi.org\/10.1016\/j.ajo.2016.05.013","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"3696_CR15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/archophthalmol.2009.24","volume":"127","author":"HA Ferreyra","year":"2009","unstructured":"Ferreyra HA, Jayasundera T, Khan NW et al (2009) Management of autoimmune retinopathies with immunosuppression. Arch Ophthalmol 127(4):390\u2013397. https:\/\/doi.org\/10.1001\/archophthalmol.2009.24","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"3696_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12348-011-0028-8","volume":"1","author":"G Adamus","year":"2011","unstructured":"Adamus G, Brown L, Schiffman J, Iannaccone A (2011) Diversity in autoimmunity against retinal, neuronal, and axonal antigens in acquired neuro-retinopathy. J Ophthalmic Inflamm Infect 1(3):111\u2013121. https:\/\/doi.org\/10.1007\/s12348-011-0028-8","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"3696_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2415-4-5","volume":"4","author":"G Adamus","year":"2004","unstructured":"Adamus G, Ren G, Weleber RG (2004) Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol 4:5. https:\/\/doi.org\/10.1186\/1471-2415-4-5","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"3696_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12348-019-0171-1","volume":"9","author":"S Khanna","year":"2019","unstructured":"Khanna S, Martins A, Oakey Z et al (2019) Non-paraneoplastic autoimmune retinopathy: multimodal testing characteristics of 13 cases. J Ophthalmic Inflamm Infect 9(1):6. https:\/\/doi.org\/10.1186\/s12348-019-0171-1","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"3696_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.21037\/aes-19-113","volume":"5","author":"H Lin","year":"2020","unstructured":"Lin H, Dao D, Sen HN (2020) Diagnosis and treatment of autoimmune retinopathy. Ann Eye Sci 5:27. https:\/\/doi.org\/10.21037\/aes-19-113","journal-title":"Ann Eye Sci"},{"key":"3696_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115643","volume":"214","author":"C Chen","year":"2023","unstructured":"Chen C, Ding P, Yan W et al (2023) Pharmacological roles of lncRNAs in diabetic retinopathy with a focus on oxidative stress and inflammation. Biochem Pharmacol 214:115643. https:\/\/doi.org\/10.1016\/j.bcp.2023.115643","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"3696_CR21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jcjd.2020.10.009","volume":"45","author":"AS ValdezGuerrero","year":"2021","unstructured":"ValdezGuerrero AS, Quintana-P\u00e9rez JC, Arellano-Mendoza MG et al (2021) Diabetic retinopathy: important biochemical alterations and the main treatment strategies. Can J Diabetes 45(6):504\u2013511. https:\/\/doi.org\/10.1016\/j.jcjd.2020.10.009","journal-title":"Can J Diabetes"},{"key":"3696_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.672444","volume":"8","author":"G Adamus","year":"2021","unstructured":"Adamus G (2021) Importance of autoimmune responses in progression of retinal degeneration initiated by gene mutations. Front Med (Lausanne) 8:672444. https:\/\/doi.org\/10.3389\/fmed.2021.672444","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"3696_CR23","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/ni.3731","volume":"18","author":"AN Theofilopoulos","year":"2017","unstructured":"Theofilopoulos AN, Kono DH, Baccala R (2017) The multiple pathways to autoimmunity. Nat Immunol 18(7):716\u2013724. https:\/\/doi.org\/10.1038\/ni.3731","journal-title":"Nat Immunol"},{"issue":"8","key":"3696_CR24","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1080\/02713689808951259","volume":"17","author":"P Charukamnoetkanok","year":"1998","unstructured":"Charukamnoetkanok P, Fukushima A, Whitcup SM et al (1998) Expression of ocular autoantigens in the mouse thymus. Curr Eye Res 17(8):788\u2013792","journal-title":"Curr Eye Res"},{"issue":"1","key":"3696_CR25","doi-asserted-by":"publisher","first-page":"14226","DOI":"10.1038\/s41598-017-14618-z","volume":"7","author":"V Voigt","year":"2017","unstructured":"Voigt V, Wikstrom ME, Kezic JM et al (2017) Ocular antigen does not cause disease unless presented in the context of inflammation. Sci Rep 7(1):14226. https:\/\/doi.org\/10.1038\/s41598-017-14618-z","journal-title":"Sci Rep"},{"issue":"3","key":"3696_CR26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2174\/157339511796196584","volume":"7","author":"SW McPherson","year":"2011","unstructured":"McPherson SW, Heuss ND, Lehman U et al (2011) Generation of regulatory T cells to antigen expressed in the retina. Curr Immunol Rev 7(3):344\u2013349. https:\/\/doi.org\/10.2174\/157339511796196584","journal-title":"Curr Immunol Rev"},{"issue":"6","key":"3696_CR27","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006957","volume":"4","author":"Y Xing","year":"2012","unstructured":"Xing Y, Hogquist KA (2012) T-cell tolerance: central and peripheral. Cold Spring Harb Perspect Biol 4(6):a006957. https:\/\/doi.org\/10.1101\/cshperspect.a006957","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"3696_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/ni0207-124","volume":"8","author":"JA Hill","year":"2007","unstructured":"Hill JA, Benoist C, Mathis D (2007) Treg cells: guardians for life. Nat Immunol 8(2):124\u2013125. https:\/\/doi.org\/10.1038\/ni0207-124","journal-title":"Nat Immunol"},{"issue":"9","key":"3696_CR29","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3389\/fimmu.2018.00765","volume":"16","author":"G Adamus","year":"2018","unstructured":"Adamus G (2018) Are anti-retinal autoantibodies a cause or a consequence of retinal degeneration in autoimmune retinopathies? Front Immunol 16(9):765. https:\/\/doi.org\/10.3389\/fimmu.2018.00765","journal-title":"Front Immunol"},{"issue":"20","key":"3696_CR30","doi-asserted-by":"publisher","first-page":"9176","DOI":"10.1073\/pnas.92.20.9176","volume":"92","author":"AS Polans","year":"1995","unstructured":"Polans AS, Witkowska D, Haley TL et al (1995) Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci USA 92(20):9176\u20139180. https:\/\/doi.org\/10.1073\/pnas.92.20.9176","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3696_CR31","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1002\/ijc.22458","volume":"120","author":"AV Bazhin","year":"2007","unstructured":"Bazhin AV, Schadendorf D, Willner N et al (2007) Photoreceptor proteins as cancer-retina antigens. Int J Cancer 120(6):1268\u20131276. https:\/\/doi.org\/10.1002\/ijc.22458","journal-title":"Int J Cancer"},{"key":"3696_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.580636","volume":"11","author":"G Wildner","year":"2020","unstructured":"Wildner G, Diedrichs-M\u00f6hring M (2020) Molecular mimicry and uveitis. Front Immunol 11:580636. https:\/\/doi.org\/10.3389\/fimmu.2020.580636","journal-title":"Front Immunol"},{"key":"3696_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3389\/fimmu.2017.00505","volume":"8","author":"G Adamus","year":"2017","unstructured":"Adamus G (2017) Impact of autoantibodies against glycolytic enzymes on pathogenicity of autoimmune retinopathy and other autoimmune disorders. Front Immunol 8:505. https:\/\/doi.org\/10.3389\/fimmu.2017.00505","journal-title":"Front Immunol"},{"key":"3696_CR34","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2147\/OPTH.S404826","volume":"17","author":"P Rujkorakarn","year":"2023","unstructured":"Rujkorakarn P, Margolis MJ, Morvey D, Zhou Y, Foster CS (2023) Limited clinical value of anti-retinal antibody titers and numbers in autoimmune retinopathy. Clin Ophthalmol 17:749\u2013755. https:\/\/doi.org\/10.2147\/OPTH.S404826","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"3696_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.5.3.1","volume":"5","author":"S Yang","year":"2016","unstructured":"Yang S, Dizhoor A, Wilson DJ et al (2016) GCAP1, Rab6, and HSP27: novel autoantibody targets in cancer-associated retinopathy and autoimmune retinopathy. Transl Vis Sci Technol 5(3):1. https:\/\/doi.org\/10.1167\/tvst.5.3.1","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"3696_CR36","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/IAE.0000000000000119","volume":"34","author":"DS Grewal","year":"2014","unstructured":"Grewal DS, Fishman GA, Jampol LM (2014) Autoimmune retinopathy and antiretinal antibodies: a review. Retina 34(5):827\u2013845. https:\/\/doi.org\/10.1097\/IAE.0000000000000119","journal-title":"Retina"},{"key":"3696_CR37","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/B978-1-4557-0737-9.00077-1","volume-title":"Retina","author":"HN Sen","year":"2013","unstructured":"Sen HN, Nussenblatt RB (2013) Autoimmune retinopathies. In: Ryan SJ (ed) Retina, 5th edn. Elsevier, London, pp 1381\u20131389","edition":"5"},{"issue":"2","key":"3696_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s1568-9972(02)00127-1","volume":"2","author":"G Adamus","year":"2003","unstructured":"Adamus G (2003) Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy. Autoimmun Rev 2(2):63\u201368. https:\/\/doi.org\/10.1016\/s1568-9972(02)00127-1","journal-title":"Autoimmun Rev"},{"issue":"2","key":"3696_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/IIO.0000000000000063","volume":"55","author":"F Forooghian","year":"2015","unstructured":"Forooghian F, Cao S, Cui J et al (2015) The enigma of autoimmune retinopathy. Int Ophthalmol Clin 55(2):81\u201391. https:\/\/doi.org\/10.1097\/IIO.0000000000000063","journal-title":"Int Ophthalmol Clin"},{"issue":"5","key":"3696_CR40","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1128\/CDLI.8.5.853-858.2001","volume":"8","author":"JJ Hooks","year":"2001","unstructured":"Hooks JJ, Tso MO, Detrick B (2001) Retinopathies associated with antiretinal antibodies. Clin Diagn Lab Immunol 8(5):853\u2013858. https:\/\/doi.org\/10.1128\/CDLI.8.5.853-858.2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"3696_CR41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jaut.2009.02.001","volume":"32","author":"G Adamus","year":"2009","unstructured":"Adamus G, Karren L (2009) Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy. J Autoimmun 32(2):133\u2013139. https:\/\/doi.org\/10.1016\/j.jaut.2009.02.001","journal-title":"J Autoimmun"},{"issue":"2","key":"3696_CR42","first-page":"283","volume":"38","author":"G Adamus","year":"1997","unstructured":"Adamus G, Machnicki M, Seigel GM (1997) Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy. Investig Ophthalmol Vis Sci 38(2):283\u2013291","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"3696_CR43","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1006\/geno.1993.1345","volume":"17","author":"TA Morris","year":"1993","unstructured":"Morris TA, Fong SL (1993) Characterization of the gene encoding human cone transducin alpha-subunit (GNAT2). Genomics 17(2):442\u2013448. https:\/\/doi.org\/10.1006\/geno.1993.1345","journal-title":"Genomics"},{"issue":"7","key":"3696_CR44","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/humu.9499","volume":"28","author":"V Szabo","year":"2007","unstructured":"Szabo V, Kreienkamp HJ, Rosenberg T et al (2007) p.Gln200Glu, a putative constitutively active mutant of rod alpha-transducin (GNAT1) in autosomal dominant congenital stationary night blindness. Hum Mutat 28(7):741\u2013742. https:\/\/doi.org\/10.1002\/humu.9499","journal-title":"Hum Mutat"},{"issue":"3","key":"3696_CR45","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1167\/iovs.11-8026","volume":"53","author":"MA Naeem","year":"2012","unstructured":"Naeem MA, Chavali VR, Ali S et al (2012) GNAT1 associated with autosomal recessive congenital stationary night blindness. Investig Ophthalmol Vis Sci 53(3):1353\u20131361. https:\/\/doi.org\/10.1167\/iovs.11-8026","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"8","key":"3696_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069506","volume":"8","author":"WH Xiong","year":"2013","unstructured":"Xiong WH, Duvoisin RM, Adamus G et al (2013) Serum TRPM1 autoantibodies from melanoma associated retinopathy patients enter retinal on-bipolar cells and attenuate the electroretinogram in mice. PLoS ONE 8(8):e69506. https:\/\/doi.org\/10.1371\/journal.pone.0069506","journal-title":"PLoS ONE"},{"issue":"7","key":"3696_CR47","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1097\/IAE.0b013e3182398107","volume":"32","author":"LH Lima","year":"2012","unstructured":"Lima LH, Greenberg JP, Greenstein VC et al (2012) Hyperautofluorescent ring in autoimmune retinopathy. Retina 32(7):1385\u20131394. https:\/\/doi.org\/10.1097\/IAE.0b013e3182398107","journal-title":"Retina"},{"key":"3696_CR48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2174\/1874364100903010020","volume":"3","author":"X Cao","year":"2009","unstructured":"Cao X, Bishop RJ, Forooghian F et al (2009) Autoimmune retinopathy in systemic lupus erythematosus: histopathologic features. Open Ophthalmol J 3:20\u201325. https:\/\/doi.org\/10.2174\/1874364100903010020","journal-title":"Open Ophthalmol J"},{"issue":"4","key":"3696_CR49","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ajo.2008.05.046","volume":"146","author":"F Forooghian","year":"2008","unstructured":"Forooghian F, Macdonald IM, Heckenlively JR et al (2008) The need for standardization of antiretinal antibody detection and measurement. Am J Ophthalmol 146(4):489\u2013495. https:\/\/doi.org\/10.1016\/j.ajo.2008.05.046","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"3696_CR50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/s0002-9394(98)00149-4","volume":"126","author":"SM Whitcup","year":"1998","unstructured":"Whitcup SM, Vistica BP, Milam AH et al (1998) Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. Am J Ophthalmol 126(2):230\u2013237. https:\/\/doi.org\/10.1016\/s0002-9394(98)00149-4","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"3696_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019911","volume":"6","author":"M Kondo","year":"2011","unstructured":"Kondo M, Sanuki R, Ueno S et al (2011) Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction. PLoS ONE 6(5):e19911. https:\/\/doi.org\/10.1371\/journal.pone.0019911","journal-title":"PLoS ONE"},{"issue":"11","key":"3696_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081507","volume":"8","author":"S Ueno","year":"2013","unstructured":"Ueno S, Nishiguchi KM, Tanioka H et al (2013) Degeneration of retinal on bipolar cells induced by serum including autoantibody against TRPM1 in mouse model of paraneoplastic retinopathy. PLoS ONE 8(11):e81507. https:\/\/doi.org\/10.1371\/journal.pone.0081507","journal-title":"PLoS ONE"},{"issue":"4","key":"3696_CR53","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2415-4-5","volume":"4","author":"G Adamus","year":"2004","unstructured":"Adamus G, Ren G, Weleber RG (2004) Autoantibodies against retinal proteins in paraneoplastic and auto-immune retinopathy. BMC Ophthalmol 4(4):5. https:\/\/doi.org\/10.1186\/1471-2415-4-5","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"3696_CR54","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jaut.2005.11.007","volume":"26","author":"G Adamus","year":"2006","unstructured":"Adamus G, Webb S, Shiraga S et al (2006) Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells. J Autoimmun 26(2):146\u2013153. https:\/\/doi.org\/10.1016\/j.jaut.2005.11.007","journal-title":"J Autoimmun"},{"issue":"2","key":"3696_CR55","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10875-006-9065-8","volume":"27","author":"A Magrys","year":"2007","unstructured":"Magrys A, Anekonda T, Ren G, Adamus G (2007) The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy. J Clin Immunol 27(2):181\u2013192. https:\/\/doi.org\/10.1007\/s10875-006-9065-8","journal-title":"J Clin Immunol"},{"issue":"1","key":"3696_CR56","first-page":"262","volume":"41","author":"B Lei","year":"2000","unstructured":"Lei B, Bush RA, Milam AH et al (2000) Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Investig Ophthalmol Vis Sci 41(1):262\u2013266","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"12","key":"3696_CR57","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1016\/j.ophtha.2013.07.037","volume":"120","author":"MD Dalal","year":"2013","unstructured":"Dalal MD, Morgans CW, Duvoisin RM et al (2013) Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach. Ophthalmology 120(12):2560\u20132564. https:\/\/doi.org\/10.1016\/j.ophtha.2013.07.037","journal-title":"Ophthalmology"},{"issue":"115","key":"3696_CR58","first-page":"T8","volume":"8","author":"HN Sen","year":"2018","unstructured":"Sen HN, Grange L, Akanda M, Fox A (2018) Autoimmune retinopathy: current concepts and practices (an American ophthalmological society thesis). Trans Am Ophthalmol Soc 8(115):T8","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"3","key":"3696_CR59","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1373\/clinchem.2007.098368","volume":"54","author":"N Vermeulen","year":"2008","unstructured":"Vermeulen N, Arijs I, Joossens S et al (2008) Anti-alpha-enolase antibodies in patients with inflammatory Bowel disease. Clin Chem 54(3):534\u2013541. https:\/\/doi.org\/10.1373\/clinchem.2007.098368","journal-title":"Clin Chem"},{"issue":"8","key":"3696_CR60","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00417-006-0527-8","volume":"245","author":"F Forooghian","year":"2007","unstructured":"Forooghian F, Adamus G, Sproule M, Westall C, O\u2019Connor P (2007) Enolase autoantibodies and retinal function in multiple sclerosis patients. Graefes Arch Clin Exp Ophthalmol 245(8):1077\u20131084","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2 Suppl 53","key":"3696_CR61","first-page":"S63","volume":"27","author":"JH Lee","year":"2009","unstructured":"Lee JH, Cho SB, Bang D, Oh SH, Ahn KJ, Kim J, Park YB, Lee SK, Lee KH (2009) Human anti-alpha-enolase antibody in sera from patients with Beh\u00e7et\u2019s disease and rheumatologic disorders. Clin Exp Rheumatol 27(2 Suppl 53):S63\u2013S66","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"3696_CR62","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1365-2567.2005.02173.x","volume":"115","author":"N Patel","year":"2005","unstructured":"Patel N, Ohbayashi M, Nugent AK et al (2005) Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology 115(3):422\u2013430. https:\/\/doi.org\/10.1111\/j.1365-2567.2005.02173.x","journal-title":"Immunology"},{"issue":"43","key":"3696_CR63","doi-asserted-by":"publisher","first-page":"42027","DOI":"10.1074\/jbc.M305460200","volume":"278","author":"X Gu","year":"2003","unstructured":"Gu X, Meer SG, Miyagi M et al (2003) Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem 278(43):42027\u201342035. https:\/\/doi.org\/10.1074\/jbc.M305460200","journal-title":"J Biol Chem"},{"issue":"4","key":"3696_CR64","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1001\/archophthalmol.2011.65","volume":"129","author":"AC Ko","year":"2011","unstructured":"Ko AC, Brinton JP, Mahajan VB et al (2011) Seroreactivity against aqueous-soluble and detergent-soluble retinal proteins in posterior uveitis. Arch Ophthalmol 129(4):415\u2013420. https:\/\/doi.org\/10.1001\/archophthalmol.2011.65","journal-title":"Arch Ophthalmol"},{"issue":"1\u20132","key":"3696_CR65","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jneuroim.2012.10.007","volume":"254","author":"M Kyger","year":"2013","unstructured":"Kyger M, Worley A, Adamus G (2013) Autoimmune responses against photoreceptor antigens during retinal degeneration and their role in macrophage recruitment into retinas of RCS rats. J Neuroimmunol 254(1\u20132):91\u2013100. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.10.007","journal-title":"J Neuroimmunol"},{"issue":"5","key":"3696_CR66","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.ajo.2004.12.104","volume":"139","author":"RG Weleber","year":"2005","unstructured":"Weleber RG, Watzke RC, Shults WT et al (2005) Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol 139(5):780\u2013794. https:\/\/doi.org\/10.1016\/j.ajo.2004.12.104","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"3696_CR67","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/ICU.0b013e3283654e1e","volume":"24","author":"DU Comlekoglu","year":"2013","unstructured":"Comlekoglu DU, Thompson IA, Sen HN (2013) Autoimmune retinopathy. Curr Opin Ophthalmol 24(6):598\u2013605. https:\/\/doi.org\/10.1097\/ICU.0b013e3283654e1e","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"3696_CR68","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/j.jcjo.2014.04.007","volume":"49","author":"DR Almeida","year":"2014","unstructured":"Almeida DR, Chin EK, Niles P et al (2014) Unilateral manifestation of autoimmune retinopathy. Can J Ophthalmol 49(4):e85\u2013e87. https:\/\/doi.org\/10.1016\/j.jcjo.2014.04.007","journal-title":"Can J Ophthalmol"},{"issue":"3","key":"3696_CR69","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/0036933015598124","volume":"61","author":"Z Javaid","year":"2016","unstructured":"Javaid Z, Rehan SM, Al-Bermani A et al (2016) Unilateral cancer-associated retinopathy: a case report. Scott Med J 61(3):155\u2013159. https:\/\/doi.org\/10.1177\/0036933015598124","journal-title":"Scott Med J"},{"issue":"4","key":"3696_CR70","doi-asserted-by":"publisher","first-page":"e601","DOI":"10.1111\/aos.13981","volume":"97","author":"MH Errera","year":"2019","unstructured":"Errera MH, Robson AG, Wong T et al (2019) Unilateral pigmentary retinopathy: a retrospective case series. Acta Ophthalmol 97(4):e601\u2013e617. https:\/\/doi.org\/10.1111\/aos.13981","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"3696_CR71","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1097\/IAE.0b013e318206d155","volume":"31","author":"AG Robson","year":"2011","unstructured":"Robson AG, Tufail A, Fitzke F, Bird AC, Moore AT, Holder GE, Webster AR (2011) Serial imaging and structure-function correlates of high-density rings of fundus autofluorescence in retinitis pigmentosa. Retina 31(8):1670\u20131679. https:\/\/doi.org\/10.1097\/IAE.0b013e318206d155","journal-title":"Retina"},{"issue":"5","key":"3696_CR72","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/ICB.0000000000000872","volume":"15","author":"DS Grewal","year":"2021","unstructured":"Grewal DS, Jaffe GJ, Keenan RT (2021) Sarilumab for recalcitrant cystoid macular edema in non-paraneoplastic autoimmune retinopathy. Retin Cases Brief Rep 15(5):504\u2013508. https:\/\/doi.org\/10.1097\/ICB.0000000000000872","journal-title":"Retin Cases Brief Rep"},{"issue":"4","key":"3696_CR73","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/ICB.0000000000000766","volume":"14","author":"AP Finn","year":"2020","unstructured":"Finn AP, Keenan RT, Jaffe GJ (2020) Reconstitution of the ellipsoid zone with tocilizumab in autoimmune retinopathy. Retin Cases Brief Rep 14(4):297\u2013300. https:\/\/doi.org\/10.1097\/ICB.0000000000000766","journal-title":"Retin Cases Brief Rep"},{"issue":"3","key":"3696_CR74","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/08820530500350662","volume":"21","author":"N Khan","year":"2006","unstructured":"Khan N, Huang JJ, Foster CS (2006) Cancer associated retinopathy (CAR): an autoimmune-mediated paraneoplastic syndrome. Semin Ophthalmol 21(3):135\u2013141. https:\/\/doi.org\/10.1080\/08820530500350662","journal-title":"Semin Ophthalmol"},{"issue":"6","key":"3696_CR75","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.ajo.2004.01.010","volume":"137","author":"H Ohguro","year":"2004","unstructured":"Ohguro H, Yokoi Y, Ohguro I, Mamiya K, Ishikawa F, Yamazaki H, Metoki T, Takano Y, Ito T, Nakazawa M (2004) Clinical and immunologic aspects of cancer-associated retinopathy. Am J Ophthalmol 137(6):1117\u20131119. https:\/\/doi.org\/10.1016\/j.ajo.2004.01.010","journal-title":"Am J Ophthalmol"},{"key":"3696_CR76","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1741-7015-11-73","volume":"11","author":"J C\u00e1rdenas-Rold\u00e1n","year":"2013","unstructured":"C\u00e1rdenas-Rold\u00e1n J, Rojas-Villarraga A, Anaya JM (2013) How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med 11:73. https:\/\/doi.org\/10.1186\/1741-7015-11-73","journal-title":"BMC Med"},{"issue":"Pt 6","key":"3696_CR77","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/eye.1997.227","volume":"11","author":"H Kiratli","year":"1997","unstructured":"Kiratli H, Thirkill CE, Bilgi\u00e7 S et al (1997) Paraneoplastic retinopathy associated with metastatic cutaneous melanoma of unknown primary site. Eye (Lond) 11(Pt 6):889\u2013892. https:\/\/doi.org\/10.1038\/eye.1997.227","journal-title":"Eye (Lond)"},{"issue":"3","key":"3696_CR78","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00041327-200109000-00004","volume":"21","author":"JL Keltner","year":"2001","unstructured":"Keltner JL, Thirkill CE, Yip PT (2001) Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuroophthalmology 21(3):173\u2013187. https:\/\/doi.org\/10.1097\/00041327-200109000-00004","journal-title":"J Neuroophthalmology"},{"issue":"3","key":"3696_CR79","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/WNO.0000000000000280","volume":"35","author":"LK Gordon","year":"2015","unstructured":"Gordon LK (2015) Paraneoplastic Syndromes in Neuro-Ophthalmology. J Neuroophthalmol 35(3):306\u2013314. https:\/\/doi.org\/10.1097\/WNO.0000000000000280","journal-title":"J Neuroophthalmol"},{"issue":"21","key":"3696_CR80","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.3390\/diagnostics13213376","volume":"13","author":"A Akhavanrezayat","year":"2023","unstructured":"Akhavanrezayat A, Khatri A, Onghanseng NGL et al (2023) Structural and functional changes in non-paraneoplastic autoimmune retinopathy. Diagnostics (Basel) 13(21):3376. https:\/\/doi.org\/10.3390\/diagnostics13213376","journal-title":"Diagnostics (Basel)"},{"key":"3696_CR81","doi-asserted-by":"publisher","unstructured":"Pepple KL, Cusick M, Jaffe GJ et al (2013) SD-OCT and autofluorescence characteristics of autoimmune retinopathy. Br J Ophthalmol 97(2):139\u201344. https:\/\/doi.org\/10.1136\/bjophthalmol-2012-302524. Epub 2012 Dec 5. Erratum in: Br J Ophthalmol 2014;98(5):713","DOI":"10.1136\/bjophthalmol-2012-302524"},{"issue":"6","key":"3696_CR82","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/s41433-020-01380-2","volume":"35","author":"IH Yusuf","year":"2021","unstructured":"Yusuf IH, Foot B, Lotery AJ (2021) The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary. Eye (Lond) 35(6):1532\u20131537. https:\/\/doi.org\/10.1038\/s41433-020-01380-2","journal-title":"Eye (Lond)"},{"key":"3696_CR83","doi-asserted-by":"publisher","unstructured":"Abazari A, Allam SS, Adamus G et al (2012) Optical coherence tomography findings in autoimmune retinopathy. Am J Ophthalmol 153(4):750\u2013756, 756.e1. https:\/\/doi.org\/10.1016\/j.ajo.2011.09.012","DOI":"10.1016\/j.ajo.2011.09.012"},{"issue":"6","key":"3696_CR84","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2174\/1566524015666150731104626","volume":"15","author":"YJ Sepah","year":"2015","unstructured":"Sepah YJ, Sadiq MA, Hassan M et al (2015) Assessment of retinal structural and functional characteristics in eyes with autoimmune retinopathy. Curr Mol Med 15(6):578\u2013586. https:\/\/doi.org\/10.2174\/1566524015666150731104626","journal-title":"Curr Mol Med"},{"issue":"1","key":"3696_CR85","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12886-017-0638-5","volume":"17","author":"YC Kuo","year":"2017","unstructured":"Kuo YC, Chen N, Tsai RK (2017) Acute zonal occult outer retinopathy (AZOOR): a case report of vision improvement after intravitreal injection of Ozurdex. BMC Ophthalmol 17(1):236. https:\/\/doi.org\/10.1186\/s12886-017-0638-5","journal-title":"BMC Ophthalmol"},{"key":"3696_CR86","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ajoc.2017.08.001","volume":"8","author":"FJ Irizarry","year":"2017","unstructured":"Irizarry FJ, Kopplin LJ, Salek SS et al (2017) Recovery of outer retinal laminations on optical coherence tomography after treatment of cancer associated retinopathy. Am J Ophthalmol Case Rep 8:11\u201313. https:\/\/doi.org\/10.1016\/j.ajoc.2017.08.001","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"2","key":"3696_CR87","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/s0896-1549(03)00006-3","volume":"16","author":"K Holopigian","year":"2003","unstructured":"Holopigian K, Hood DC (2003) Electrophysiology. Ophthalmol Clin North Am 16(2):237\u2013251. https:\/\/doi.org\/10.1016\/s0896-1549(03)00006-3","journal-title":"Ophthalmol Clin North Am"},{"issue":"1","key":"3696_CR88","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/IAE.0b013e3181853d06","volume":"29","author":"B Link","year":"2009","unstructured":"Link B, Schl\u00f6tzer-Schrehardt U, J\u00fcnemann A (2009) Carcinoma-associated retinopathy-an electrophysiological and immunohistochemical correlation. Retina 29(1):69\u201372. https:\/\/doi.org\/10.1097\/IAE.0b013e3181853d06","journal-title":"Retina"},{"issue":"11","key":"3696_CR89","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00417-006-0319-1","volume":"244","author":"AB Renner","year":"2006","unstructured":"Renner AB, Kellner U, Cropp E et al (2006) Dysfunction of transmission in the inner retina: incidence and clinical causes of negative electroretinogram. Graefes Arch Clin Exp Ophthalmol 244(11):1467\u20131473. https:\/\/doi.org\/10.1007\/s00417-006-0319-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"3696_CR90","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/archopht.1993.01090070049018","volume":"111","author":"CE Thirkill","year":"1993","unstructured":"Thirkill CE, Keltner JL, Tyler NK et al (1993) Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy. Arch Ophthalmol 111(7):931\u2013937. https:\/\/doi.org\/10.1001\/archopht.1993.01090070049018","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"3696_CR91","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10633-014-9456-8","volume":"129","author":"S Machida","year":"2014","unstructured":"Machida S, Ohguro H, Ishida K et al (2014) Recoverin-associated retinopathy secondary to Warthin tumor of parotid gland. Doc Ophthalmol 129(2):123\u2013128. https:\/\/doi.org\/10.1007\/s10633-014-9456-8","journal-title":"Doc Ophthalmol"},{"issue":"5","key":"3696_CR92","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00417-012-2131-4","volume":"251","author":"W Saito","year":"2013","unstructured":"Saito W, Kase S, Ohguro H et al (2013) Autoimmune retinopathy associated with colonic adenoma. Graefes Arch Clin Exp Ophthalmol 251(5):1447\u20131449. https:\/\/doi.org\/10.1007\/s00417-012-2131-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3696_CR93","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ajoc.2018.09.005","volume":"12","author":"JL Cheng","year":"2018","unstructured":"Cheng JL, Beebe JD, Nepple KG et al (2018) Autoimmune retinopathy and optic neuropathy associated with enolase-positive renal oncocytoma. Am J Ophthalmol Case Rep 12:55\u201360. https:\/\/doi.org\/10.1016\/j.ajoc.2018.09.005","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"5","key":"3696_CR94","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.autrev.2009.01.002","volume":"8","author":"G Adamus","year":"2009","unstructured":"Adamus G (2009) Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmun Rev 8(5):410\u2013414. https:\/\/doi.org\/10.1016\/j.autrev.2009.01.002","journal-title":"Autoimmun Rev"},{"issue":"1","key":"3696_CR95","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/s0165-5728(99)00163-0","volume":"103","author":"T Kikuchi","year":"2000","unstructured":"Kikuchi T, Arai J, Shibuki H et al (2000) Tubby-like protein 1 as an autoantigen in cancer-associated retinopathy. J Neuroimmunol 103(1):26\u201333. https:\/\/doi.org\/10.1016\/s0165-5728(99)00163-0","journal-title":"J Neuroimmunol"},{"issue":"5","key":"3696_CR96","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1167\/iovs.17-21443","volume":"58","author":"RM Duvoisin","year":"2017","unstructured":"Duvoisin RM, Haley TL, Ren G et al (2017) Autoantibodies in melanoma-associated retinopathy recognize an epitope conserved between TRPM1 and TRPM3. Investig Ophthalmol Vis Sci 58(5):2732\u20132738. https:\/\/doi.org\/10.1167\/iovs.17-21443","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"11","key":"3696_CR97","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1523\/JNEUROSCI.6007-10.2011","volume":"31","author":"A Dhingra","year":"2011","unstructured":"Dhingra A, Fina ME, Neinstein A et al (2011) Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells. J Neurosci 31(11):3962\u20133967. https:\/\/doi.org\/10.1523\/JNEUROSCI.6007-10.2011","journal-title":"J Neurosci"},{"issue":"2","key":"3696_CR98","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0014-5793(92)80433-h","volume":"302","author":"JF McGinnis","year":"1992","unstructured":"McGinnis JF, Stepanik PL, Baehr W et al (1992) Cloning and sequencing of the 23 kDa mouse photoreceptor cell-specific protein. FEBS Lett 302(2):172\u2013176. https:\/\/doi.org\/10.1016\/0014-5793(92)80433-h","journal-title":"FEBS Lett"},{"issue":"9","key":"3696_CR99","first-page":"2626","volume":"34","author":"G Adamus","year":"1993","unstructured":"Adamus G, Guy J, Schmied JL et al (1993) Role of anti-recoverin autoantibodies in cancer-associated retinopathy. Investig Ophthalmol Vis Sci 34(9):2626\u20132633","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3696_CR100","first-page":"181","volume-title":"Neuronal calcium sensor protein","author":"G Adamus","year":"2006","unstructured":"Adamus G (2006) The role of recoverin in autoimmunity. In: Philippov PP, Koch KW (eds) Neuronal calcium sensor protein. Nova Science Publisher, Inc., New York, pp 181\u2013200"},{"issue":"1","key":"3696_CR101","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/s0169-5002(01)00212-4","volume":"34","author":"AV Bazhin","year":"2001","unstructured":"Bazhin AV, Shifrina ON, Savchenko MS et al (2001) Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision. Lung Cancer 34(1):99\u2013104. https:\/\/doi.org\/10.1016\/s0169-5002(01)00212-4","journal-title":"Lung Cancer"},{"issue":"6","key":"3696_CR102","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4172\/2155-9570.1000307","volume":"4","author":"G Adamus","year":"2013","unstructured":"Adamus G, Choi D, Raghunath A et al (2013) Significance of anti-retinal autoantibodies in cancer-associated retinopathy with gynecological cancers. J Clin Exp Ophthalmol 4(6):307. https:\/\/doi.org\/10.4172\/2155-9570.1000307","journal-title":"J Clin Exp Ophthalmol"},{"issue":"3\u20134","key":"3696_CR103","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jaut.2009.09.003","volume":"33","author":"K Morohoshi","year":"2009","unstructured":"Morohoshi K, Goodwin AM, Ohbayashi M, Ono SJ (2009) Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration. J Autoimmun 33(3\u20134):247\u2013254. https:\/\/doi.org\/10.1016\/j.jaut.2009.09.003","journal-title":"J Autoimmun"},{"issue":"12","key":"3696_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167909","volume":"11","author":"JC Ten Berge","year":"2016","unstructured":"Ten Berge JC, van Rosmalen J, Vermeer J et al (2016) Serum autoantibody profiling of patients with paraneoplastic and non-paraneoplastic autoimmune retinopathy. PLoS ONE 11(12):e0167909. https:\/\/doi.org\/10.1371\/journal.pone.0167909","journal-title":"PLoS ONE"},{"issue":"1","key":"3696_CR105","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/s0002-9394(02)01431-9","volume":"134","author":"MJ Potter","year":"2002","unstructured":"Potter MJ, Adamus G, Szabo SM et al (2002) Autoantibodies to transducin in a patient with melanoma-associated retinopathy. Am J Ophthalmol 134(1):128\u2013130. https:\/\/doi.org\/10.1016\/s0002-9394(02)01431-9","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"3696_CR106","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.lungcan.2003.10.006","volume":"44","author":"AV Bazhin","year":"2004","unstructured":"Bazhin AV, Savchenko MS, Shifrina ON et al (2004) Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors. Lung Cancer 44(2):193\u2013198. https:\/\/doi.org\/10.1016\/j.lungcan.2003.10.006","journal-title":"Lung Cancer"},{"issue":"1","key":"3696_CR107","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/ijc.23909","volume":"124","author":"AV Bazhin","year":"2009","unstructured":"Bazhin AV, Dalke C, Willner N et al (2009) Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy. Int J Cancer 124(1):140\u2013149. https:\/\/doi.org\/10.1002\/ijc.23909","journal-title":"Int J Cancer"},{"issue":"1","key":"3696_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/s0952523800003175","volume":"10","author":"AH Milam","year":"1993","unstructured":"Milam AH, Dacey DM, Dizhoor AM (1993) Recoverin immunoreactivity in mammalian cone bipolar cells. Vis Neurosci 10(1):1\u201312. https:\/\/doi.org\/10.1017\/s0952523800003175","journal-title":"Vis Neurosci"},{"issue":"2","key":"3696_CR109","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaut.2004.06.003","volume":"23","author":"G Ren","year":"2004","unstructured":"Ren G, Adamus G (2004) Cellular targets of anti-alpha-enolase autoantibodies of patients with autoimmune retinopathy. J Autoimmun 23(2):161\u2013167. https:\/\/doi.org\/10.1016\/j.jaut.2004.06.003","journal-title":"J Autoimmun"},{"issue":"1","key":"3696_CR110","first-page":"82","volume":"40","author":"H Ohguro","year":"1999","unstructured":"Ohguro H, Ogawa K, Nakagawa T (1999) Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy. Invest Ophthalmol Vis Sci 40(1):82\u201389","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3696_CR111","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2415-13-48","volume":"13","author":"G Adamus","year":"2013","unstructured":"Adamus G, Bonnah R, Brown L et al (2013) Detection of autoantibodies against heat shock proteins and collapsin response mediator proteins in autoimmune retinopathy. BMC Ophthalmol 13:48. https:\/\/doi.org\/10.1186\/1471-2415-13-48","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"3696_CR112","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1158\/1541-7786.MCR-07-0140","volume":"6","author":"AV Bazhin","year":"2008","unstructured":"Bazhin AV, Schadendorf D, Owen RW et al (2008) Visible light modulates the expression of cancer-retina antigens. Mol Cancer Res 6(1):110\u2013118. https:\/\/doi.org\/10.1158\/1541-7786.MCR-07-0140","journal-title":"Mol Cancer Res"},{"issue":"1","key":"3696_CR113","first-page":"91","volume":"34","author":"AH Milam","year":"1993","unstructured":"Milam AH, Saari JC, Jacobson SG et al (1993) Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Investig Ophthalmol Vis Sci 34(1):91\u2013100","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"3696_CR114","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/ijc.20762","volume":"114","author":"TB Hartmann","year":"2005","unstructured":"Hartmann TB, Bazhin AV, Schadendorf D et al (2005) Serex identification of new tumor antigens linked to melanoma-associated retinopathy. Int J Cancer 114(1):88\u201393. https:\/\/doi.org\/10.1002\/ijc.20762","journal-title":"Int J Cancer"},{"issue":"4","key":"3696_CR115","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/ijc.22384","volume":"120","author":"C Pf\u00f6hler","year":"2007","unstructured":"Pf\u00f6hler C, Preuss KD, Tilgen W et al (2007) Mitofilin and titin as target antigens in melanoma-associated retinopathy. Int J Cancer 120(4):788\u2013795. https:\/\/doi.org\/10.1002\/ijc.22384","journal-title":"Int J Cancer"},{"issue":"3","key":"3696_CR116","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/archopht.126.3.432","volume":"126","author":"L Eksandh","year":"2008","unstructured":"Eksandh L, Adamus G, Mosgrove L et al (2008) Autoantibodies against bestrophin in a patient with vitelliform paraneoplastic retinopathy and a metastatic choroidal malignant melanoma. Arch Ophthalmol 126(3):432\u2013435. https:\/\/doi.org\/10.1001\/archopht.126.3.432","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"3696_CR117","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.ophtha.2015.05.027","volume":"122","author":"EH van Dijk","year":"2015","unstructured":"van Dijk EH, van Herpen CM, Marinkovic M et al (2015) Serous retinopathy associated with mitogen-activated protein kinase kinase inhibition (Binimetinib) for metastatic cutaneous and uveal melanoma. Ophthalmology 122(9):1907\u20131916. https:\/\/doi.org\/10.1016\/j.ophtha.2015.05.027","journal-title":"Ophthalmology"},{"issue":"1","key":"3696_CR118","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/archophthalmol.2010.316","volume":"129","author":"L Koreen","year":"2011","unstructured":"Koreen L, He SX, Johnson MW et al (2011) Anti-retinal pigment epithelium antibodies in acute exudative polymorphous vitelliform maculopathy: a new hypothesis about disease pathogenesis. Arch Ophthalmol 129(1):23\u201329. https:\/\/doi.org\/10.1001\/archophthalmol.2010.316","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"3696_CR119","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00281-008-0114-7","volume":"30","author":"JR Heckenlively","year":"2008","unstructured":"Heckenlively JR, Ferreyra HA (2008) Autoimmune retinopathy: a review and summary. Semin Immunopathol 30(2):127\u2013134. https:\/\/doi.org\/10.1007\/s00281-008-0114-7","journal-title":"Semin Immunopathol"},{"issue":"1","key":"3696_CR120","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00417-010-1436-4","volume":"249","author":"K Ohta","year":"2011","unstructured":"Ohta K, Kikuchi T, Yoshida N (2011) Slowly progressive non-neoplastic autoimmune-like retinopathy. Graefes Arch Clin Exp Ophthalmol 249(1):155\u2013158. https:\/\/doi.org\/10.1007\/s00417-010-1436-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"3696_CR121","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3349\/ymj.2016.57.2.527","volume":"57","author":"EY Choi","year":"2016","unstructured":"Choi EY, Kim M, Adamus G et al (2016) Non-paraneoplastic autoimmune retinopathy: the first case report in Korea. Yonsei Med J 57(2):527\u2013531. https:\/\/doi.org\/10.3349\/ymj.2016.57.2.527","journal-title":"Yonsei Med J"},{"key":"3696_CR122","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2147\/OPTH.S404826","volume":"17","author":"P Rujkorakarn","year":"2023","unstructured":"Rujkorakarn P, Margolis MJ, Morvey D et al (2023) Limited clinical value of anti-retinal antibody titers and numbers in autoimmune retinopathy. Clin Ophthalmol 17:749\u2013755. https:\/\/doi.org\/10.2147\/OPTH.S404826","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"3696_CR123","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/s0002-9394(98)00446-2","volume":"127","author":"JR Heckenlively","year":"1999","unstructured":"Heckenlively JR, Jordan BL, Aptsiauri N (1999) Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 127(5):565\u2013573. https:\/\/doi.org\/10.1016\/s0002-9394(98)00446-2","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"3696_CR124","doi-asserted-by":"publisher","first-page":"1000104e","DOI":"10.4172\/2155-9570.1000104e","volume":"2","author":"G Adamus","year":"2011","unstructured":"Adamus G (2011) Is zonal occult outer retinopathy an autoimmune disease? J Clin Exp Ophthalmol 2(9):1000104e. https:\/\/doi.org\/10.4172\/2155-9570.1000104e","journal-title":"J Clin Exp Ophthalmol"},{"key":"3696_CR125","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ajo.2016.12.001","volume":"176","author":"CX Qian","year":"2017","unstructured":"Qian CX, Wang A, DeMill DL et al (2017) Prevalence of antiretinal antibodies in acute zonal occult outer retinopathy: a comprehensive review of 25 cases. Am J Ophthalmol 176:210\u2013218. https:\/\/doi.org\/10.1016\/j.ajo.2016.12.001","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"3696_CR126","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/WNO.0b013e318167549f","volume":"28","author":"K Shimazaki","year":"2008","unstructured":"Shimazaki K, Jirawuthiworavong GV, Heckenlively JR, Gordon LK (2008) Frequency of anti-retinal antibodies in normal human serum. J Neuroophthalmol 28(1):5\u201311. https:\/\/doi.org\/10.1097\/WNO.0b013e318167549f","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"3696_CR127","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/archophthalmol.2009.51","volume":"127","author":"LM Jampol","year":"2009","unstructured":"Jampol LM, Fishman GA (2009) Immunosuppression for autoimmune retinopathy. Arch Ophthalmol 127(4):573\u2013575. https:\/\/doi.org\/10.1001\/archophthalmol.2009.51","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"3696_CR128","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/09273940902818861","volume":"17","author":"CP Herbort","year":"2009","unstructured":"Herbort CP, Rao NA, Mochizuki M, members of Scientific Committee of First International Workshop on Ocular Sarcoidosis (2009) International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm 17(3):160\u2013169. https:\/\/doi.org\/10.1080\/09273940902818861","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"3696_CR129","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1097\/IAE.0b013e3181e097f0","volume":"30","author":"T Fujiwara","year":"2010","unstructured":"Fujiwara T, Imamura Y, Giovinazzo VJ et al (2010) Fundus autofluorescence and optical coherence tomographic findings in acute zonal occult outer retinopathy. Retina 30(8):1206\u20131216. https:\/\/doi.org\/10.1097\/IAE.0b013e3181e097f0","journal-title":"Retina"},{"issue":"1","key":"3696_CR130","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1001\/archophthalmol.2009.368","volume":"128","author":"S Yeh","year":"2010","unstructured":"Yeh S, Forooghian F, Wong WT et al (2010) Fundus autofluorescence imaging of the white dot syndromes. Arch Ophthalmol 128(1):46\u201356. https:\/\/doi.org\/10.1001\/archophthalmol.2009.368","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"3696_CR131","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/ceo.13917","volume":"49","author":"M Georgiou","year":"2021","unstructured":"Georgiou M, Fujinami K, Michaelides M (2021) Inherited retinal diseases: therapeutics, clinical trials and end points\u2014a review. Clin Exp Ophthalmol 49(3):270\u2013288. https:\/\/doi.org\/10.1111\/ceo.13917","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"3696_CR132","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/s0967-5868(97)90106-5","volume":"4","author":"CL Scott","year":"1997","unstructured":"Scott CL, Cher LM, O\u2019Day J (1997) Cancer associated retinopathy and non-small cell lung cancer. J Clin Neurosci 4(3):355\u2013357. https:\/\/doi.org\/10.1016\/s0967-5868(97)90106-5","journal-title":"J Clin Neurosci"},{"issue":"2","key":"3696_CR133","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10633-013-9398-6","volume":"127","author":"RE Stead","year":"2013","unstructured":"Stead RE, Fox MA, Staples E et al (2013) Delayed presentation of melanoma-associated retinopathy and subsequent resolution with cytoreduction surgery. Doc Ophthalmol 127(2):165\u2013171. https:\/\/doi.org\/10.1007\/s10633-013-9398-6","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"3696_CR134","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12886-018-0948-2","volume":"18","author":"F Hoogewoud","year":"2018","unstructured":"Hoogewoud F, Butori P, Blanche P et al (2018) Cancer-associated retinopathy preceding the diagnosis of cancer. BMC Ophthalmol 18(1):285. https:\/\/doi.org\/10.1186\/s12886-018-0948-2","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"3696_CR135","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/ced.14095","volume":"45","author":"S Elsheikh","year":"2020","unstructured":"Elsheikh S, Gurney SP, Burdon MA (2020) Melanoma-associated retinopathy. Clin Exp Dermatol 45(2):147\u2013152. https:\/\/doi.org\/10.1111\/ced.14095","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"3696_CR136","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11940-009-0057-x","volume":"12","author":"SF Powell","year":"2010","unstructured":"Powell SF, Dudek AZ (2010) Treatment of melanoma-associated retinopathy. Curr Treat Options Neurol 12(1):54\u201363. https:\/\/doi.org\/10.1007\/s11940-009-0057-x","journal-title":"Curr Treat Options Neurol"},{"issue":"1","key":"3696_CR137","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archopht.1992.01080130050025","volume":"110","author":"JL Keltner","year":"1992","unstructured":"Keltner JL, Thirkill CE, Tyler NK, Roth AM (1992) Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol 110(1):48\u201353. https:\/\/doi.org\/10.1001\/archopht.1992.01080130050025","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"3696_CR138","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3341\/kjo.2018.0091","volume":"33","author":"MS Kim","year":"2019","unstructured":"Kim MS, Hong HK, Park KH et al (2019) Intravitreal dexamethasone implant with plasma autoantibody monitoring for cancer-associated retinopathy. Korean J Ophthalmol 33(3):298\u2013300. https:\/\/doi.org\/10.3341\/kjo.2018.0091","journal-title":"Korean J Ophthalmol"},{"issue":"3","key":"3696_CR139","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12348-012-0067-9","volume":"2","author":"N Huynh","year":"2012","unstructured":"Huynh N, Shildkrot Y, Lobo AM et al (2012) Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy. J Ophthalmic Inflamm Infect 2(3):169\u2013171. https:\/\/doi.org\/10.1007\/s12348-012-0067-9","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"10","key":"3696_CR140","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1001\/archderm.140.10.1258","volume":"140","author":"C Jacobzone","year":"2004","unstructured":"Jacobzone C, Cochard-Marianowski C, Kupfer I et al (2004) Corticosteroid treatment for melanoma-associated retinopathy: effect on visual acuity and electrophysiologic findings. Arch Dermatol 140(10):1258\u20131261. https:\/\/doi.org\/10.1001\/archderm.140.10.1258","journal-title":"Arch Dermatol"},{"issue":"4","key":"3696_CR141","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/archopht.117.4.471","volume":"117","author":"J Guy","year":"1999","unstructured":"Guy J, Aptsiauri N (1999) Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Ophthalmol 117(4):471\u2013477. https:\/\/doi.org\/10.1001\/archopht.117.4.471","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"3696_CR142","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/jamaophthalmol.2019.0284","volume":"137","author":"E Karatsai","year":"2019","unstructured":"Karatsai E, Robson AG, Taylor SRJ (2019) Outcomes associated with sustained-release intraocular fluocinolone implants in a case of melanoma-associated retinopathy treated without systemic immunosuppression. JAMA Ophthalmol 137(5):564\u2013567. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.0284","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"3696_CR143","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000353408","volume":"227","author":"A Audemard","year":"2013","unstructured":"Audemard A, de Raucourt S, Miocque S et al (2013) Melanoma-associated retinopathy treated with ipilimumab therapy. Dermatology 227(2):146\u2013149. https:\/\/doi.org\/10.1159\/000353408","journal-title":"Dermatology"},{"issue":"2","key":"3696_CR144","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/09273948.2012.754906","volume":"21","author":"A Breunig","year":"2013","unstructured":"Breunig A, Lee MS, Miller BS et al (2013) Autoimmune retinopathy in a patient with autoimmune polyendocrine syndrome type I. Ocul Immunol Inflamm 21(2):153\u2013157. https:\/\/doi.org\/10.3109\/09273948.2012.754906","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"3696_CR145","doi-asserted-by":"publisher","first-page":"416","DOI":"10.4103\/ijo.IJO_838_16","volume":"65","author":"S Abraham","year":"2017","unstructured":"Abraham S, Sudharshan S, Bhende M et al (2017) Antiretinal antibody- proven autoimmune retinopathy. Indian J Ophthalmol 65(5):416\u2013420. https:\/\/doi.org\/10.4103\/ijo.IJO_838_16","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"3696_CR146","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/ICB.0b013e3182618d55","volume":"7","author":"CJ Lin","year":"2013","unstructured":"Lin CJ, Chen SN, Hwang JF et al (2013) Nonparaneoplastic autoimmune retinopathy presenting with peripheral retinal vasoocclusion: case report. Retin Cases Brief Rep 7(1):41\u201345. https:\/\/doi.org\/10.1097\/ICB.0b013e3182618d55","journal-title":"Retin Cases Brief Rep"},{"issue":"6","key":"3696_CR147","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3109\/09273948.2013.799215","volume":"21","author":"M Oray","year":"2013","unstructured":"Oray M, Kir N, Tuncer S et al (2013) Autoimmune retinopathies: a report of 3 cases. Ocul Immunol Inflamm 21(6):424\u2013433. https:\/\/doi.org\/10.3109\/09273948.2013.799215","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"3696_CR148","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4103\/tjo.tjo_40_17","volume":"7","author":"W Wuthisiri","year":"2017","unstructured":"Wuthisiri W, Lai YH, Capasso J et al (2017) Autoimmune retinopathy associated with systemic lupus erythematosus: a diagnostic dilemma. Taiwan J Ophthalmol 7(3):172\u2013176. https:\/\/doi.org\/10.4103\/tjo.tjo_40_17","journal-title":"Taiwan J Ophthalmol"},{"issue":"3","key":"3696_CR149","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s004170050221","volume":"237","author":"H Steffen","year":"1999","unstructured":"Steffen H, Menger N, Richter W et al (1999) Immune-mediated retinopathy in a patient with stiff-man syndrome. Graefes Arch Clin Exp Ophthalmol 237(3):212\u2013219. https:\/\/doi.org\/10.1007\/s004170050221","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"3696_CR150","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1080\/09273948.2019.1636094","volume":"28","author":"MD Benson","year":"2020","unstructured":"Benson MD, Plemel DJA, Yacyshyn E et al (2020) Combination treatment with rituximab and bortezomib in a patient with non-paraneoplastic autoimmune retinopathy. Ocul Immunol Inflamm 28(6):958\u2013965. https:\/\/doi.org\/10.1080\/09273948.2019.1636094","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"3696_CR151","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1053\/j.seminhematol.2010.01.011","volume":"47","author":"GJ Weiner","year":"2010","unstructured":"Weiner GJ (2010) Rituximab: mechanism of action. Semin Hematol 47(2):115\u2013123. https:\/\/doi.org\/10.1053\/j.seminhematol.2010.01.011","journal-title":"Semin Hematol"},{"issue":"4","key":"3696_CR152","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.4049\/jimmunol.1600089","volume":"197","author":"E Schuh","year":"2016","unstructured":"Schuh E, Berer K, Mulazzani M et al (2016) Features of human CD3+CD20+ T cells. J Immunol 197(4):1111\u20131117. https:\/\/doi.org\/10.4049\/jimmunol.1600089","journal-title":"J Immunol"},{"issue":"4","key":"3696_CR153","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3109\/09273941003802379","volume":"18","author":"N Mahdi","year":"2010","unstructured":"Mahdi N, Faia LJ, Goodwin J et al (2010) A case of autoimmune retinopathy associated with thyroid carcinoma. Ocul Immunol Inflamm 18(4):322\u2013323. https:\/\/doi.org\/10.3109\/09273941003802379","journal-title":"Ocul Immunol Inflamm"},{"issue":"11","key":"3696_CR154","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.6004\/jnccn.2013.0156","volume":"11","author":"I Dy","year":"2013","unstructured":"Dy I, Chintapatla R, Preeshagul I et al (2013) Treatment of cancer-associated retinopathy with rituximab. J Natl Compr Cancer Netw 11(11):1320\u20131324","journal-title":"J Natl Compr Cancer Netw"},{"issue":"2","key":"3696_CR155","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/j.jcjo.2012.11.010","volume":"48","author":"C Or","year":"2013","unstructured":"Or C, Collins DR, Merkur AB et al (2013) Intravenous rituximab for the treatment of cancer-associated retinopathy. Can J Ophthalmol 48(2):e35\u2013e38. https:\/\/doi.org\/10.1016\/j.jcjo.2012.11.010","journal-title":"Can J Ophthalmol"},{"issue":"6","key":"3696_CR156","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/j.jcjo.2015.08.009","volume":"50","author":"A Fox","year":"2015","unstructured":"Fox A, Jeffrey B, Hasni S et al (2015) Rituximab treatment for nonparaneoplastic autoimmune retinopathy. Can J Ophthalmol 50(6):e101\u2013e104. https:\/\/doi.org\/10.1016\/j.jcjo.2015.08.009","journal-title":"Can J Ophthalmol"},{"key":"3696_CR157","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ajoc.2016.03.007","volume":"2","author":"G Uludag","year":"2016","unstructured":"Uludag G, Onal S, Arf S et al (2016) Electroretinographic improvement after rituximab therapy in a patient with autoimmune retinopathy. Am J Ophthalmol Case Rep 2:4\u20137. https:\/\/doi.org\/10.1016\/j.ajoc.2016.03.007","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"3","key":"3696_CR158","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10633-017-9605-y","volume":"135","author":"D Roels","year":"2017","unstructured":"Roels D, Ueno S, Talianu CD et al (2017) Unilateral cancer-associated retinopathy: diagnosis, serology and treatment. Doc Ophthalmol 135(3):233\u2013240. https:\/\/doi.org\/10.1007\/s10633-017-9605-y","journal-title":"Doc Ophthalmol"},{"key":"3696_CR159","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ajo.2017.04.019","volume":"180","author":"S Davoudi","year":"2017","unstructured":"Davoudi S, Ebrahimiadib N, Yasa C, Sevgi DD, Roohipoor R, Papavasilieou E, Comander J, Sobrin L (2017) Outcomes in autoimmune retinopathy patients treated with rituximab. Am J Ophthalmol 180:124\u2013132. https:\/\/doi.org\/10.1016\/j.ajo.2017.04.019","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"3696_CR160","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13023-017-0680-7","volume":"12","author":"K Boudreault","year":"2017","unstructured":"Boudreault K, Justus S, Sengillo JD et al (2017) Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy. Orphanet J Rare Dis 12(1):129. https:\/\/doi.org\/10.1186\/s13023-017-0680-7","journal-title":"Orphanet J Rare Dis"},{"key":"3696_CR161","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2147\/OPTH.S120162","volume":"11","author":"A Maleki","year":"2017","unstructured":"Maleki A, Lamba N, Ma L et al (2017) Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy. Clin Ophthalmol 11:377\u2013385. https:\/\/doi.org\/10.2147\/OPTH.S120162","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"3696_CR162","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11060-006-9326-7","volume":"83","author":"L Espandar","year":"2007","unstructured":"Espandar L, O\u2019Brien S, Thirkill C et al (2007) Successful treatment of cancer-associated retinopathy with alemtuzumab. J Neurooncol 83(3):295\u2013302. https:\/\/doi.org\/10.1007\/s11060-006-9326-7","journal-title":"J Neurooncol"},{"issue":"6","key":"3696_CR163","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nri3834","volume":"15","author":"D Brenner","year":"2015","unstructured":"Brenner D, Blaser H, Mak TW (2015) Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol 15(6):362\u2013374. https:\/\/doi.org\/10.1038\/nri3834","journal-title":"Nat Rev Immunol"},{"issue":"19","key":"3696_CR164","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ et al (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295(19):2275\u20132285. https:\/\/doi.org\/10.1001\/jama.295.19.2275","journal-title":"JAMA"},{"issue":"2","key":"3696_CR165","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/pds.2046","volume":"20","author":"J Askling","year":"2011","unstructured":"Askling J, Fahrbach K, Nordstrom B et al (2011) Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data. Pharmacoepidemiol Drug Saf 20(2):119\u2013130. https:\/\/doi.org\/10.1002\/pds.2046","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"3696_CR166","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T (2014) IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 6(10):a016295. https:\/\/doi.org\/10.1101\/cshperspect.a016295","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3696_CR167","doi-asserted-by":"publisher","unstructured":"Kalogeropoulos D, Kanavaros P, Vartholomatos G et al (2023) Cytokines in Immune-mediated \"Non-infectious\" Uveitis. Klin Monbl Augenheilkd. English. https:\/\/doi.org\/10.1055\/a-2202-8704","DOI":"10.1055\/a-2202-8704"},{"issue":"2","key":"3696_CR168","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/09273948.2019.1681471","volume":"29","author":"L Ramos-Ruperto","year":"2021","unstructured":"Ramos-Ruperto L, Busca-Arenzana C, Boto-de Los Bueis A et al (2021) Cancer-associated retinopathy and treatment with intravenous immunoglobulin therapy: a seldom used approach? Ocul Immunol Inflamm 29(2):399\u2013402. https:\/\/doi.org\/10.1080\/09273948.2019.1681471","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"3696_CR169","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrneurol.2014.253","volume":"11","author":"JD L\u00fcnemann","year":"2015","unstructured":"L\u00fcnemann JD, Nimmerjahn F, Dalakas MC (2015) Intravenous immunoglobulin in neurology\u2013mode of action and clinical efficacy. Nat Rev Neurol 11(2):80\u201389. https:\/\/doi.org\/10.1038\/nrneurol.2014.253","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"3696_CR170","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/jca.20302","volume":"26","author":"DM Ward","year":"2011","unstructured":"Ward DM (2011) Conventional apheresis therapies: a review. J Clin Apher 26(5):230\u2013238. https:\/\/doi.org\/10.1002\/jca.20302","journal-title":"J Clin Apher"},{"issue":"Suppl 1","key":"3696_CR171","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1097\/ICB.0000000000000395","volume":"11","author":"DI Sierpina","year":"2017","unstructured":"Sierpina DI, Skale DM, Fan JT (2017) Effect of plasmapheresis and passage of anti-retinal antibodies through the placenta in a case of non-paraneoplastic autoimmune retinopathy. Retin Cases Brief Rep 11(Suppl 1):S34\u2013S37. https:\/\/doi.org\/10.1097\/ICB.0000000000000395","journal-title":"Retin Cases Brief Rep"},{"issue":"4","key":"3696_CR172","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3109\/01658107.2015.1050744","volume":"39","author":"SJ Almarzouqi","year":"2015","unstructured":"Almarzouqi SJ, Morgan ML, Carvounis PE et al (2015) Autoimmune-related retinopathy and optic neuropathy accompanied by anti-GAD antibodies. Neuroophthalmology 39(4):195\u2013200. https:\/\/doi.org\/10.3109\/01658107.2015.1050744","journal-title":"Neuroophthalmology"},{"key":"3696_CR173","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ajo.2018.08.044","volume":"196","author":"R Ando","year":"2018","unstructured":"Ando R, Saito W, Kanda A et al (2018) Clinical features of japanese patients with anti-\u03b1-enolase antibody-positive autoimmune retinopathy: novel subtype of multiple drusen. Am J Ophthalmol 196:181\u2013196. https:\/\/doi.org\/10.1016\/j.ajo.2018.08.044","journal-title":"Am J Ophthalmol"},{"issue":"7116","key":"3696_CR174","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nature05161","volume":"444","author":"RE MacLaren","year":"2006","unstructured":"MacLaren RE, Pearson RA, MacNeil A et al (2006) Retinal repair by transplantation of photoreceptor precursors. Nature 444(7116):203\u2013207. https:\/\/doi.org\/10.1038\/nature05161","journal-title":"Nature"},{"issue":"2","key":"3696_CR175","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nbt1384","volume":"26","author":"F Osakada","year":"2008","unstructured":"Osakada F, Ikeda H, Mandai M et al (2008) Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotechnol 26(2):215\u2013224. https:\/\/doi.org\/10.1038\/nbt1384","journal-title":"Nat Biotechnol"},{"issue":"8","key":"3696_CR176","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/stem.674","volume":"29","author":"JS Meyer","year":"2011","unstructured":"Meyer JS, Howden SE, Wallace KA et al (2011) Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells 29(8):1206\u20131218. https:\/\/doi.org\/10.1002\/stem.674","journal-title":"Stem Cells"},{"issue":"8","key":"3696_CR177","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.1167\/iovs.10-6329","volume":"52","author":"J Gust","year":"2011","unstructured":"Gust J, Reh TA (2011) Adult donor rod photoreceptors integrate into the mature mouse retina. Investig Ophthalmol Vis Sci 52(8):5266\u20135272. https:\/\/doi.org\/10.1167\/iovs.10-6329","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"7","key":"3696_CR178","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1097\/IAE.0b013e3181e2a680","volume":"30","author":"AA Vugler","year":"2010","unstructured":"Vugler AA (2010) Progress toward the maintenance and repair of degenerating retinal circuitry. Retina 30(7):983\u20131001. https:\/\/doi.org\/10.1097\/IAE.0b013e3181e2a680","journal-title":"Retina"},{"issue":"11","key":"3696_CR179","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/stem.520","volume":"28","author":"EL West","year":"2010","unstructured":"West EL, Pearson RA, Barker SE, Luhmann UF, Maclaren RE, Barber AC, Duran Y, Smith AJ, Sowden JC, Ali RR (2010) Long-term survival of photoreceptors transplanted into the adult murine neural retina requires immune modulation. Stem Cells 28(11):1997\u20132007. https:\/\/doi.org\/10.1002\/stem.520","journal-title":"Stem Cells"},{"issue":"1","key":"3696_CR180","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/APO.0000000000000594","volume":"12","author":"D Kalogeropoulos","year":"2023","unstructured":"Kalogeropoulos D, Asproudis I, Stefaniotou M et al (2023) The large hellenic study of uveitis: diagnostic and therapeutic algorithms, complications, and final outcome. Asia Pac J Ophthalmol (Phila) 12(1):44\u201357. https:\/\/doi.org\/10.1097\/APO.0000000000000594","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"1","key":"3696_CR181","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2021-000889","volume":"7","author":"JS Heng","year":"2022","unstructured":"Heng JS, Kim JM, Jones DK et al (2022) Autoimmune retinopathy with associated anti-retinal antibodies as a potential immune-related adverse event associated with immunotherapy in patients with advanced cutaneous melanoma: case series and systematic review. BMJ Open Ophthalmol 7(1):e000889. https:\/\/doi.org\/10.1136\/bmjophth-2021-000889","journal-title":"BMJ Open Ophthalmol"},{"issue":"1","key":"3696_CR182","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/jamaophthalmol.2013.574","volume":"131","author":"S Faez","year":"2013","unstructured":"Faez S, Loewenstein J, Sobrin L (2013) Concordance of antiretinal antibody testing results between labora-tories in autoimmune retinopathy. JAMA Ophthalmol 131(1):113\u2013115. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.574","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"3696_CR183","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1155\/1993\/796390","volume":"4","author":"H Artsob","year":"1993","unstructured":"Artsob H (1993) Western Blot as a confirmatory test for Lyme disease. Can J Infect Dis 4(2):115\u2013116. https:\/\/doi.org\/10.1155\/1993\/796390","journal-title":"Can J Infect Dis"},{"issue":"3","key":"3696_CR184","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ophtha.2003.05.036","volume":"111","author":"HN Sen","year":"2004","unstructured":"Sen HN, Chan CC, Caruso RC, Fariss RN, Nussenblatt RB, Buggage RR (2004) Waldenstr\u00f6m\u2019s macroglobulinemia-associated retinopathy. Ophthalmology 111(3):535\u2013539. https:\/\/doi.org\/10.1016\/j.ophtha.2003.05.036","journal-title":"Ophthalmology"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03696-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03696-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03696-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:05:14Z","timestamp":1766167514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03696-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":184,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3696"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03696-y","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"341"}}